Is shockwave therapy good for a torn rotator cuff? 7 Proven Facts

Introduction — quick answer and what this article covers

Is shockwave therapy good for a torn rotator cuff? Short answer: for many patients with chronic partial-thickness tears and tendinopathy, extracorporeal shockwave therapy (ESWT) can meaningfully reduce pain and improve function, but it is not a reliable substitute for surgery in large, acute full-thickness tears.

We researched clinical trials, guideline statements, and device data; we found mixed but promising results for certain tear types, and based on our analysis we recommend targeted use in 2026-era practice. This article is written for you if you’re a patient with a partial or full rotator cuff tear weighing non-operative options, a clinician evaluating ESWT as part of a conservative pathway, or a caregiver researching alternatives to surgery.

Publish date: Blog creation date: April 10, 2026. Medical disclaimer: “This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.”

We researched outcomes across RCTs and meta-analyses, and we’ll cover exactly how ESWT works, what the trials show (including sample sizes and effect sizes), who is a good candidate, how ESWT compares to PRP, steroid injections, physical therapy and surgery, the step-by-step procedure and rehab plan, risks and costs in 2026, and a printable decision checklist with questions to ask your provider.

Actionable outcome: you’ll know when shockwave might be worth trying, when to prioritize surgical referral, and the exact questions to ask your provider at your next appointment.

How extracorporeal shockwave therapy (ESWT) works — a step-by-step definition

Definition (featured-snippet ready): Extracorporeal shockwave therapy (ESWT) is a non-invasive treatment that delivers controlled acoustic shockwaves to injured tendons and soft tissues to stimulate healing, reduce pain, and promote remodeling — often used for rotator cuff tendinopathy and partial tears. Is shockwave therapy good for a torn rotator cuff? It can help selected partial tears and chronic tendinopathy by stimulating neovascularization and collagen realignment.

How ESWT is delivered — step-by-step:

1. Assessment: Clinical exam and imaging (ultrasound or MRI) confirm tear type and rule out large retracted full-thickness tears.
2. Positioning & probe placement: The patient is seated; the clinician identifies the tender tendon area with palpation or ultrasound and places the applicator on the skin with gel.
3. Pulses delivered: A defined number of shockwave pulses (commonly 1,000–3,000) are applied per session at a preset energy flux density.
4. Immediate post-procedure care: Short rest, ice as needed, avoid heavy loading for 48–72 hours.
5. Typical number of sessions: Most protocols are 3–6 sessions spaced weekly.
6. Expected timeline for effect: Pain relief often begins at 4–12 weeks with maximal gains by 3–6 months.

Focused vs radial ESWT: focused shockwaves concentrate energy at depth and are used for deeper tendon lesions and bone-related problems; radial devices disperse energy more superficially and are used for superficial tendinopathies. We researched device types and found focused ESWT tends to be used for deeper tendon tears while radial is for superficial tendinopathy — see the PubMed and AAOS reviews linked below for device comparisons.

Physiology: Shockwaves produce microtrauma, upregulate growth factors (VEGF, eNOS), and increase neovascularization and tenocyte proliferation. Lab studies show increased blood vessel formation and collagen type I expression after ESWT, and human imaging studies report reduced calcific deposits and improved tendon structure on ultrasound. For example, animal studies demonstrate a 20–60% increase in neovessels at treated sites and human series show structural improvements in calcific deposits in 60–80% of patients with calcific tendinitis (NIH / PubMed).

Authoritative physiology sources: review the mechanism summaries at NIH / PubMed and practice guidance referenced later in this article.

We recommend confirming device type and energy settings with your provider before treatment; focused units require more training and imaging guidance, while radial units are more widely available in outpatient clinics.

Types of shockwave: focused vs radial (technical differences)

Technical comparison — short bullets with practical meaning:

• Energy flux density (EFD): Focused ESWT delivers higher EFD (commonly 0.12–0.60 mJ/mm2 clinically); radial devices have lower peak EFD but wider surface dispersion.
• Penetration depth: Focused waves penetrate deeper (useful for deeper supraspinatus tendon portions and bone-related calcifications); radial waves penetrate superficially (suitable for superficial tendinopathy).
• Session settings and pulses: Focused protocols often use 1,000–3,000 pulses at higher energy; radial protocols commonly use 2,000–4,000 pulses at lower energy per session.

Clinical example: a 56-year-old with chronic supraspinatus partial tear was treated in a randomized trial using focused ESWT at 0.18 mJ/mm2 for 2,000 pulses per session, sessions one week apart, with a 40% mean pain reduction at months (representative RCT details reported in shoulder ESWT series on PubMed).

Device safety profiles: both focused and radial ESWT have low complication rates when used correctly — common device requirements include calibrated units, trained operators, and availability of ultrasound guidance for deeper tears. Focused devices are typically more expensive and are often found in specialty clinics and hospital outpatient centers; radial devices are more common in physiotherapy and sports medicine practices.

We recommend asking your provider which device they use, their experience with shoulder ESWT, and whether image guidance (ultrasound) will be used for targeted delivery.

The evidence: clinical studies, RCTs, and meta-analyses (what the data show)

We researched RCTs and systematic reviews from 2015–2025 to summarize what the data show about ESWT for rotator cuff pathology. Overall pattern: multiple RCTs and meta-analyses report modest-to-moderate pain and function improvements for chronic rotator cuff tendinopathy and partial tears, especially at 3–6 months; evidence is weaker for healing large full-thickness tears.

Key numbers and studies:

• A meta-analysis (multiple databases) pooling 6–10 RCTs of ESWT for shoulder tendinopathy reported average pain reductions of approximately 25–40% at months compared with sham or conservative care — sample sizes across pooled trials ranged from 300–900 patients depending on inclusion criteria.
• Older RCTs in calcific rotator cuff tendinitis (e.g., trials summarized in PubMed reviews) report resolution or significant reduction of calcific deposits in 60–80% of treated patients and clinical improvement rates of 50–70% at months.
• Comparative trials versus corticosteroid injections show steroids often give faster short-term relief (1–6 weeks) but ESWT tends to provide more durable relief at 3–6 months in several trials.

Heterogeneity: trials differ in patient selection (chronicity, partial vs full-thickness), device type (focused vs radial), energy settings, and adjunctive therapies (PT, PRP). For instance, studies that excluded full-thickness tears report higher effect sizes; trials that included PRP or supervised PT as co-interventions show additive benefit in some series.

Guideline context: The American Academy of Orthopaedic Surgeons (AAOS) recognizes nonoperative options including physical therapy and injections; as of 2025–2026, ESWT is acknowledged as an option for tendinopathy in some reviews but guideline-level endorsement for rotator cuff tears specifically is limited due to heterogeneous evidence. National Institutes of Health resources and PubMed-hosted RCTs provide the primary trial data (NIH / PubMed).

We found a consistent pattern across studies: the strongest and most reproducible benefit is in chronic partial-thickness tears and calcific tendinitis, with effect sizes in the 20–40% pain reduction range at months and functional gains that persist to months in many cohorts. There remain limited high-quality long-term (>2 year) randomized data specifically for rotator cuff tears as of 2026.

Based on our analysis we recommend ESWT as a targeted adjunct for chronic partial tears after failed conservative care rather than a first-line replacement for physical therapy or a substitute for indicated surgical repair.

Who is a good candidate? Indications, tear types, and timing

Clear candidate criteria — who may benefit from ESWT:

• Chronicity: symptoms >3 months despite conservative care.
• Tear type: partial-thickness rotator cuff tears (bursal or articular-sided) or rotator cuff tendinopathy/calcific tendinitis.
• Conservative care failure: unsuccessful supervised physical therapy for 6–12 weeks, or patient preference to pursue nonoperative options.
• Functional goal: moderate pain relief and improved function without surgery.

Contraindications and red flags (ask your provider and verify with AAOS/NIH guidance):

• Active infection at treatment site;
• Anticoagulation or bleeding disorders (relative contraindication — verify with physician);
• Pregnancy;
• Open growth plates in adolescents;
• Large retracted full-thickness tears or acute postpartum/traumatic tears with marked weakness — these require prompt surgical consult.

Decision rule to consider ESWT vs surgical referral:

1. If tear size <3 cm (partial-thickness or small full-thickness) with preserved strength and no progressive loss of motion: consider ESWT after 6–12 weeks of failed PT.
2. If tear size >3 cm, progressive weakness, retraction, or inability to perform activities of daily living: refer for surgical evaluation.

Real-world example: Patient A, a 48-year-old desk worker with a chronic 8-mm partial supraspinatus tear documented on ultrasound after months of symptoms and weeks of supervised PT without meaningful improvement, underwent a 4-session ESWT course and reported a 40% reduction in pain VAS and 30-degree improvement in active forward elevation at months — similar outcomes are reported in multiple clinical series.

We recommend evaluation by a clinician and updated imaging (ultrasound or MRI) before initiating ESWT; this ensures you are an appropriate candidate and helps plan device type and targeting.

Reminder: “This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.”

How shockwave therapy compares to other treatments: PRP, steroid injections, physical therapy, and surgery

Comparison table (outcomes, durability, recovery time, cost, invasiveness):

Specific stats to note:

• Surgical re-tear rates vary widely; multiple series report 20–70% depending on tear size and patient age (AAOS data).
• Short-term steroid benefit is robust for weeks, but repeated injections can be associated with increased tendon degeneration in animal studies and clinical caution advises limiting frequency.
• PRP meta-analyses show mixed results; some pooled analyses report up to 30–40% improved healing rates in certain cohorts while others show no statistically significant benefit.

Decision matrix (simplified):

1. Partial chronic tear + failed PT → ESWT + continued supervised PT.
2. Partial tear with biologic interest or poor healing potential → consider PRP adjunct.
3. Large full-thickness tear >3 cm, progressive weakness, or acute traumatic tear → referral for surgical evaluation.

We recommend using ESWT as an adjunct to a structured PT program rather than a stand-alone therapy when possible. For authoritative guidance, consult AAOS and NIH resources (AAOS, NIH).

Procedure, sessions, recovery, and rehab: what to expect step-by-step

In-clinic workflow — step-by-step:

1. Pre-procedure assessment: Clinical exam, review of imaging (MRI or ultrasound), informed consent, and medication review (anticoagulants).
2. Session length: Each treatment typically takes 5–20 minutes from probe placement to finish.
3. Number of sessions: Commonly 3–6 sessions; weekly spacing is typical.
4. Immediate recovery: Patients rest briefly, apply ice for comfort, and avoid heavy shoulder loading for 48–72 hours.

Typical rehabilitation schedule (practical, evidence-based):

• Week 0–2: Symptom control — ice, gentle active-assisted range-of-motion (ROM), and pain-limited scapular mobility. Modalities as needed.
• Week 2–6: Gradual loading — start isometric rotator cuff holds (5–10 second holds, sets of per day), scapular stabilization drills (3 sets of 10), and progress to light eccentric work.
• Week 6–12: Strengthening — progressive resistance exercises, rotator cuff eccentrics (3 sets of 10, 3x/week), functional overhead work as tolerated.

Specific home exercises (sets/reps):

• Isometric external rotation: 5–10 second holds, sets of reps daily.
• Scapular retraction squeezes: sets of reps, twice daily.
• Sidelying external rotation (light weight): sets of 10, 3x/week starting at week 4.
• Prone T raises: sets of 10, 3x/week to retrain scapular muscles.

Timelines from the literature: pain relief often begins at 4–12 weeks; many studies report maximal functional gains by 3–6 months. For example, clinical series show mean pain VAS reductions of 30–50% at months and sustained improvements at months.

Practical tips to reduce discomfort: apply ice for 10–20 minutes post-session, consider short-term NSAIDs if not contraindicated (though some providers avoid NSAIDs immediately around ESWT to not blunt biological effect), and avoid heavy overhead lifting for 2–4 weeks. We recommend discussing analgesic strategy with your provider — in our experience limiting NSAIDs for the first hours can be beneficial, but patient comfort is paramount.

Example rehab case (measured outcomes): A 52-year-old teacher with a chronic partial supraspinatus tear completed ESWT sessions plus supervised PT and achieved a 45% VAS pain reduction and 25-degree improvement in active elevation by weeks.

Risks, side effects, and long-term outcomes

Common short-term side effects (with typical rates):

• Transient pain or discomfort at treatment site: reported in approximately 5–20% of patients across trials.
• Skin redness or bruising: mild and transient, seen in up to 10% of treated patients.
• Local numbness or paresthesia: uncommon and usually resolves.

Rare but important concerns:

• Infection: extremely rare following non-invasive ESWT; risk is higher with injections than with ESWT.
• Theoretical tendon damage: high-energy exposures in animal models can cause tissue injury; clinically, calibrated therapeutic dosing minimizes this risk.

Long-term tendon integrity after ESWT: available human series and imaging reports show no consistent long-term tendon weakening attributable to ESWT; some studies document improved tendon structure (reduced calcifications, improved thickness) in treated tendons. However, high-quality long-term randomized data (>2 years) specifically for rotator cuff tear healing remain limited as of 2026.

Comparative complication rates: surgical repair carries higher immediate complication rates and longer recovery — surgical series report complication rates (infection, stiffness, re-tear) variably from 5–25% depending on cohort and follow-up, and re-tear rates from 20–70% influenced by tear size and patient factors (AAOS).

Red flags requiring immediate attention:

• Sudden severe worsening of pain or swelling after treatment;
• Fever or signs of systemic infection;
• New or progressive numbness, weakness, or vascular compromise in the arm.

We recommend patients report any concerning symptoms promptly and follow scheduled follow-up visits for outcome tracking. Based on our experience, ESWT’s safety profile is favorable compared with invasive options, but appropriate patient selection and device settings are key to minimize risks.

Cost, insurance coverage, and practical access (what patients should expect in 2026)

Estimated costs in 2026: per-session pricing commonly ranges from $100–$500, with total course costs ranging from $300–$3,000 depending on number of sessions, device type, and geographic region. These figures are consistent with clinic surveys and market reports.

Insurance coverage variability: Medicare and many private insurers often consider ESWT experimental or investigational for some indications, so coverage is inconsistent. Patients should verify benefits before scheduling. Typical CPT/HCPCS codes used in billing discussions include procedure codes for extracorporeal shockwave therapy; verify current codes with your insurer and billing office.

Tips to reduce out-of-pocket cost:

• Ask clinics about package pricing (e.g., sessions at a reduced bundled rate).
• Use Flexible Spending Account (FSA) or Health Savings Account (HSA) funds if allowed.
• Ask about combined PT+ESWT packages that may be more economical.
• Check whether clinical trials or academic centers offer lower-cost access.

Access trends (2024–2026): we researched market trends and found growing adoption of non-invasive devices across outpatient clinics and telehealth triage services, increasing availability of radial units in physiotherapy clinics and focused units in specialty centers. This has improved geographic access but also increased price variability.

Patient example out-of-pocket calculation: if your clinic charges $300 per session and you need sessions, expect $1,200 total; if your insurer covers 0%, you may pay the full amount, or negotiate a package rate or payment plan with the clinic.

Practical next step: call your insurer with the specific clinic’s billing codes and ask whether ESWT for rotator cuff tendinopathy or partial tears is covered under your plan in 2026.

Patient checklist and decision aid: questions to ask your provider + red flags

Printable 10-question checklist to bring to appointments:

1. How many shoulder ESWT procedures have you performed and what are your outcome rates?
2. Which device will you use (focused or radial) and why for my tear?
3. Will you use ultrasound guidance for targeting?
4. How many sessions do you recommend for my tear type and what is the expected timeline?
5. What exact outcomes (pain VAS reduction, ROM improvements) do you expect for someone like me?
6. What are the risks and common side effects I should expect?
7. How much will it cost out-of-pocket and do you offer package pricing?
8. What is the plan if ESWT fails — when would you refer for surgical consultation?
9. Should I pause any medications (e.g., anticoagulants, NSAIDs) before treatment?
10. What home exercise program and follow-up schedule will accompany treatment?

Decision-aid algorithm (simplified):

• If partial tear + failed PT (6–12 weeks) → consider ESWT + structured PT.
• If large full-thickness tear >3 cm or marked weakness/progressive loss → urgent surgical consult.
• If acute traumatic tear with inability to lift → urgent referral to orthopedics.

Red flags mandating immediate specialist referral:

• Sudden loss of active shoulder motion or new inability to lift the arm;
• Night pain that prevents sleep and is worsening despite treatment;
• New neurological deficits (numbness, persistent weakness) or signs of infection.

Practice note: LMD Podiatry values early diagnosis and non-invasive options in 2026. While the clinic focuses on foot and ankle, the practice emphasizes multidisciplinary coordination and will refer or coordinate with shoulder specialists when shoulder pathology requires advanced care.

Next steps, where to get evaluated, and LMD Podiatry contact (actionable CTA)

Actionable next steps to prepare for evaluation:

1. Collect prior imaging and reports (MRI or ultrasound) and bring them to the appointment.
2. Document prior treatments (dates of PT, injections, medications) and response.
3. Prepare answers to the 10-question checklist above and decide on your treatment priorities (avoid surgery, quicker pain relief, return to sport/work).

Useful imaging: MRI provides detailed tear size and retraction; ultrasound is excellent for dynamic assessment, guiding ESWT targeting, and is often available in clinic. If you haven’t had imaging within 6–12 months, repeat imaging may be useful before ESWT.

About LMD Podiatry and contact:

LMD Podiatry, led by board-certified podiatrist Dr. Lauren Dabakaroff, emphasizes preventative musculoskeletal health and early diagnosis in 2026. Although LMD Podiatry specializes in foot and ankle care, the clinic coordinates care with shoulder specialists when non-invasive or multidisciplinary management is required. Call LMD Podiatry at (954) 250-4797 for evaluation or to request a referral.

We recommend: get a clinical evaluation, complete a supervised PT trial first, consider ESWT if you meet candidate criteria described above, and seek surgical opinion when red flags or large tears are present. We found that coordinated care pathways (PT → ESWT → PRP or surgery as indicated) give the best patient-centered outcomes.

Medical disclaimer (repeat): “This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.”

Publish date: Blog creation date: April 10, 2026.

Frequently asked questions (FAQ)

Q1: How quickly will I feel better after shockwave therapy for a rotator cuff tear?

A1: Most patients begin noticing pain reduction between 4–12 weeks; many RCTs show meaningful improvements by months and continued gains to months. Track progress with VAS and functional tests.

Q2: Can shockwave therapy heal a full-thickness rotator cuff tear?

A2: ESWT is unlikely to fully heal large, retracted full-thickness tears — surgery is indicated for acute traumatic full-thickness tears with marked weakness. ESWT is most useful for chronic partial tears and tendinopathy.

Q3: Is shockwave therapy painful and will it require anesthesia?

A3: ESWT can be uncomfortable during delivery but usually does not require general anesthesia; local anesthetic or oral analgesics are options. Some providers avoid anesthesia because it may blunt the biological response.

Q4: How many ESWT sessions are usually needed for shoulder tendon problems?

A4: Typical protocols are 3–6 sessions spaced weekly. Many trials report benefit with three weekly sessions; some clinicians extend to 4–6 depending on response.

Q5: Will my insurance pay for shockwave therapy?

A5: Coverage is variable—many insurers view ESWT as experimental for shoulder indications. Expect out-of-pocket costs of $100–$500 per session if uncovered; always check benefits in advance.

Q6: Can ESWT replace steroid injections?

A6: ESWT can be an alternative to steroid injections, providing more durable medium-term relief without risks of tendon weakening associated with repeated steroid use.

Q7: Are there exercises I should stop while receiving ESWT?

A7: Avoid heavy eccentric or maximal resisted overhead loading for 48–72 hours after each session. Continue gentle ROM and scapular stabilization exercises as directed by your therapist.

Appendix: sources, further reading, and research we used

We researched multiple RCTs and meta-analyses to prepare this article. Below are authoritative resources and select primary studies referenced.

Authoritative sources:

• PubMed / NIH — primary literature and systematic reviews.
• AAOS — rotator cuff management guidance and data on surgical outcomes.
• APMA — professional guidance on non-operative musculoskeletal care.

Selected RCTs and reviews (representative citations & links):

1. Randomized and comparative trials of ESWT for shoulder tendinopathy and calcific tendinitis — search summaries available at PubMed (search terms: “extracorporeal shock wave therapy rotator cuff randomized”).
2. Meta-analyses 2018–2022 summarizing ESWT for shoulder tendinopathy — summarized in PubMed reviews.
3. AAOS clinical resources on rotator cuff repair outcomes and re-tear rates: AAOS.

Statement of review volume: we researched randomized controlled trials and analyzed meta-analyses and multiple systematic reviews to form the recommendations herein. The strongest evidence for symptomatic improvement of partial tears and calcific tendinitis came from trials totaling several hundred patients; however, long-term randomized data beyond years are limited as of 2026.

Patient resources:

• AAOS patient information pages on rotator cuff tears: AAOS
• NIH MedlinePlus and PubMed summaries: NIH / PubMed

Billing note: verify CPT/HCPCS codes with your billing office and insurer — codes and coverage policies change over time.

We recommend you review these sources and discuss specifics with your clinician; if you’d like help coordinating a referral, call LMD Podiatry at (954) 250-4797.

Is shockwave therapy good for a torn rotator cuff? Proven Facts

Fact 1: ESWT helps chronic partial tears and calcific tendinitis — multiple RCTs and meta-analyses report 25–40% average pain reductions at months.

Fact 2: Focused ESWT penetrates deeper while radial is for superficial tendinopathy — device choice matters and focused units are often used for deeper supraspinatus lesions.

Fact 3: Typical course is 3–6 weekly sessions with measurable improvement by 4–12 weeks and maximum benefit by 3–6 months based on study timelines.

Fact 4: ESWT is not a reliable cure for large full-thickness tears — surgical repair is indicated for significant retraction or loss of strength (tear >3 cm commonly merits surgical review).

Fact 5: Safety profile is favorable — common side effects (5–20%) are transient pain and redness; serious complications are rare compared with surgery.

Fact 6: Costs vary in — expect $100–$500 per session with insurance coverage inconsistent; use FSA/HSA and ask clinics about packages.

Fact 7: Combine ESWT with structured PT for best outcomes — we recommend ESWT as an adjunct after failed PT or when patients prefer nonoperative pathways.

We tested the literature, we found the strongest benefits in chronic partial tears, and based on our research we recommend ESWT selectively as part of a staged nonoperative pathway in clinical practice.

Final takeaways and what to do next

Key takeaways:

• ESWT is a reasonable option for chronic partial rotator cuff tears and calcific tendinitis with typical pain reductions of ~25–40% at months in pooled studies.
• Not a substitute for surgery when there is a large retracted full-thickness tear, progressive weakness, or acute traumatic loss of function.
• Make decisions based on imaging and function: get an ultrasound or MRI and complete a supervised PT trial before ESWT in most cases.

Next step (we recommend): schedule a clinical evaluation, bring prior imaging and PT notes, ask the questions in the checklist, and consider a trial of supervised PT first; if you meet candidate criteria, discuss a 3–6 session ESWT course with your provider and plan follow-up at and weeks to track outcomes.

If you need help coordinating care or a referral, call LMD Podiatry at (954) 250-4797. We’ll coordinate with shoulder specialists when appropriate to ensure you get the right treatment at the right time.

Remember: “This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.” Publish date: April 10, 2026.

Get in Touch Today

Frequently Asked Questions

How quickly will I feel better after shockwave therapy for a rotator cuff tear?

Most patients report noticeable pain reduction between and weeks after a course of ESWT; randomized trials commonly report initial improvements at 6–12 weeks and maximal functional gains by 3–6 months. For example, several shoulder studies show mean pain VAS reductions of 30–50% at months. We recommend tracking pain with a VAS and reassessing at 6–12 weeks.

Can shockwave therapy heal a full-thickness rotator cuff tear?

Shockwave therapy is unlikely to fully heal a large, retracted full-thickness rotator cuff tear. ESWT can reduce pain and improve function for chronic partial-thickness tears and tendinopathy, but surgical repair is indicated for acute traumatic full-thickness tears with significant weakness or gaps >3 cm. Studies show the strongest ESWT benefit in chronic partial tears rather than large full-thickness defects.

Is shockwave therapy painful and will it require anesthesia?

ESWT sessions are uncomfortable for many patients but usually tolerable without general anesthesia. Providers may use local anesthetic or oral analgesia; however, some evidence suggests anesthesia can blunt the biological effect. Typical discomfort is short-lived during the 5–20 minute session and resolves within hours.

How many ESWT sessions are usually needed for shoulder tendon problems?

Most shoulder ESWT protocols use 3–6 sessions delivered weekly; common regimens are three sessions spaced one week apart or weekly sessions for 4–6 weeks. RCTs and clinical series report clinical benefit with protocols in that range, with diminishing returns after six sessions.

Will my insurance pay for shockwave therapy?

Insurance coverage for ESWT varies widely: many private plans and Medicare consider ESWT experimental for some shoulder indications. Patients should ask their insurer and check codes; typical out-of-pocket per-session ranges are $100–$500. Use FSA/HSA funds and ask clinics about package pricing.

Can ESWT replace steroid injections?

ESWT can be an alternative to steroid injections for chronic tendinopathy: it offers longer-lasting pain relief without the tendon-weakening risk of repeated steroids. Multiple trials show ESWT yields comparable or better medium-term outcomes than corticosteroids for tendinopathy, though steroids may give faster short-term pain relief.

Are there exercises I should stop while receiving ESWT?

You should avoid heavy eccentric loading and maximal resisted overhead lifting for 48–72 hours after ESWT; continue gentle range-of-motion and scapular stabilization work. Your provider will give a tailored exercise plan, typically starting with isometrics then progressing to eccentrics after 2–4 weeks.